EUDA Health Holdings Ltd current report, 18 May 2023

全文

EUDA Health Holdings Ltd. Form 8-K Summary

Business Context and Reporting Period

EUDA Health Holdings Limited, a British Virgin Islands company listed on Nasdaq under EUDA and EUDAW, filed a Current Report on Form 8-K regarding Nasdaq listing compliance. The reported event occurred on May 18, 2023; the filing was signed May 19, 2023.

Financial Metrics and Liquidity

This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating or financial metrics. The company had not timely filed its Form 10-K for the fiscal year ended December 31, 2022, or its Form 10-Q for the quarter ended March 31, 2023.

Material Changes Versus Prior Comparable Period

  • Nasdaq previously notified the company on April 5, 2023, that it was non-compliant with Nasdaq Listing Rule 5250(c)(1) because of the late 2022 Form 10-K.
  • On May 18, 2023, Nasdaq issued an additional delinquency notification because the March 31, 2023 Form 10-Q was also not timely filed.
  • Management stated that substantial portions of the required information had been completed but that additional time was needed to prepare, review, and finalize the financial statements.

Outlook, Risks, and Contingencies

  • The company was required to submit a plan to regain compliance by June 5, 2023.
  • If Nasdaq accepted the plan, it could grant an extension through September 27, 2023, to file the delinquent Form 10-K and Form 10-Q.
  • If Nasdaq rejected the plan, the company could appeal to a Nasdaq Hearings Panel. If the appeal failed, the company’s securities could be delisted.
  • The notice had no immediate effect on trading; the securities were expected to continue trading on Nasdaq under EUDA and EUDAW.
  • The filing includes customary forward-looking statement warnings regarding financial condition, results, earnings outlook, prospects, and other future developments.

Most Important Facts to Verify

  1. Whether the company submitted its compliance plan by June 5, 2023.
  2. Whether Nasdaq granted additional time and whether the company filed the delinquent 2022 Form 10-K and March 31, 2023 Form 10-Q.
  3. Whether Nasdaq initiated delisting proceedings or the company appealed any adverse determination.
  4. The company’s actual financial condition, results, cash position, debt, and liquidity once the overdue filings became available.